Plandaí Biotechnology (PLPL) 10-Q 14 May 14 2014 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Mar. 31, 2014	1-May-14
Document And Entity Information	'	'
Entity Registrant Name	'Plandai Biotechnology, Inc.	'
Entity Central Index Key	'0001317880	'
Document Type	'10-Q	'
Document Period End Date	31-Mar-14	'
Amendment Flag	'false	'
Current Fiscal Year End Date	'--06-30	'
Is Entity a Well-known Seasoned Issuer?	'No	'
Is Entity a Voluntary Filer?	'No	'
Is Entity's Reporting Status Current?	'Yes	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Common Stock, Shares Outstanding	'	128,023,828
Document Fiscal Period Focus	'Q3	'
Document Fiscal Year Focus	'2014	'

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Mar. 31, 2014	Jun. 30, 2013
Current Assets:	'	'
Cash	$626,082	$498,917
Inventory	3,272	6,439
Accounts Receivable	6,357	13,638
Total Current Assets	635,711	518,994
Deposits	82,619	10,649
Other Assets	159,582	380,929
Fixed Assets – Net	8,893,686	7,924,910
Total Assets	9,771,598	8,835,482
Current Liabilities:	'	'
Accounts Payable and Accrued Expenses	97,536	516,007
Accrued Interest	22,570	93,184
Convertible Note Payable	73,480	103,500
Derivative Liability	352,120	45,227
Related Party Payables	12,186	145,822
Total Current Liabilities	557,892	903,740
Loans from Related Parties	'	501,518
Credit Line	'	752,503
Capitalized Lease Obligation	1,290,341	988,381
Long Term Debt, Net of Discount	11,356,644	9,173,702
TOTAL LIABILITIES	13,204,877	12,319,844
STOCKHOLDERS' DEFICIT	'	'
Common Stock, authorized 500,000,000 shares, par value $0.0001, 128,023,828 and 106,270,760 shares issued and outstanding as of March 31, 2014 and June 30, 2013	12,802	10,628
Additional Paid-In Capital	15,099,420	7,833,976
Stock Subscritption Payable	'	261,600
Retained Deficit	-17,563,674	-10,903,813
Cumulative Foreign Currency Translation Adjustment	311,115	169,437
Total Stockholders' Deficit	-2,140,337	-2,628,172
Non-controlling Interest	-1,292,942	-856,190
Equity Allocated to Plandai Biotechnology	-3,433,279	-3,484,362
Total Liabilities and Stockholders' Deficit	$9,771,598	$8,835,482

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Mar. 31, 2014	Jun. 30, 2013
Statement of Financial Position [Abstract]	'	'
Common Stock, Par Value	$0.00	$0.00
Common Stock, Shares Authorized	500,000,000	500,000,000
Common Stock, Shares Issued	128,023,828	106,270,760
Common Stock, Shares Outstanding	128,023,828	106,270,760

Consolidated_Statements_Of_Ope

Consolidated Statements Of Operations (USD $)	3 Months Ended		9 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013
Income Statement [Abstract]	'	'	'	'
Revenues	$12,554	$65,850	$250,859	$313,716
Cost of Sales	141,046	356,363	483,675	720,838
Gross Profit	-128,492	-290,513	-232,816	-407,122
Expenses:	'	'	'	'
Salaries & Wages	1,133,741	115,487	2,204,284	308,523
Professional Services	29,073	114,704	108,643	184,124
Rent	175,025	189,153	431,862	216,803
Consulting Fees	800,000	'	800,000	'
Finance Costs	459,000	'	459,000	'
Research	'	'	83,230	23,098
Utilities	13,034	2,102	42,812	6,457
Insurance	8,828	24,860	27,831	101,118
Depreciation	43,774	40,500	142,808	87,822
General & Administrative	113,152	180,206	102,236	445,740
Total Expenses	2,775,627	667,012	4,402,706	1,373,685
Operating Loss	-2,904,119	-957,525	-4,635,522	-1,780,807
Other Income (Expense)	'	'	'	'
Derivative Interest	-16,004	'	-2,086,436	'
Other Income	'	'	'	2,653
Interest Expense	-134,754	-73,519	-374,654	-179,952
Net Loss	-3,054,877	-1,031,044	-7,096,612	-1,958,106
Loss Allocated to Non-controlling Interest	87,803	331,260	436,751	587,536
Net Loss, Adjusted	-2,967,074	-699,784	-6,659,861	-1,370,570
Other Comprehensive Income (loss):	'	'	'	'
Foreign Currency Translation Adjustment	143,404	127,614	141,678	133,836
Comprehensive (Loss)	($2,823,670)	($572,170)	($6,518,183)	($1,236,735)
Basic & diluted loss per share	($0.02)	($0.01)	($0.06)	($0.01)
Weighted Avg. Shares Outstanding	119,547,278	110,895,300	117,147,278	110,895,300

Consolidated_Statements_Of_Cas

Consolidated Statements Of Cash Flows (USD $)	9 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:	'	'
Net loss	($7,096,612)	($1,958,106)
Adjustments to reconcile net loss to net cash provided by operating activities:	'	'
Depreciation	142,808	87,822
Forgiveness of Interest	'	4,426
Stock Issued for Services	2,595,000	-85,000
Stock Issued for Financing Costs	459,000	'
Derivative Liability	2,086,351	'
Capitalized Lease Obligation	301,960	'
Foreign Currency Translation Adjustment	141,678	133,836
Decrease in Prepaid Expenses	'	22,068
Decrease (Increase) in Accounts Receivable	7,281	-11,516
Increase in Deposits	-71,971	'
Decrease (Increase) in Inventory	3,167	-6,742
Decrease (Increase) in Other Assets	221,348	-289,244
(Decrease) Increase in Accounts Payable and Accrued Expenses	-418,470	324,566
(Decrease) Increase in Related Party Payables	-133,636	209,297
Increase in Accrued Interest	-70,614	46,057
Net Cash Used in Operating Activities	-1,832,710	-1,522,536
CASH FLOWS FROM INVESTING ACTIVITIES:	'	'
Deposits on Equipment	'	535,498
Purchase of Fixed Assets	1,111,584	1,074,499
Net Cash Used in Investing Activities	-1,111,584	-1,609,997
CASH FLOWS FROM FINANCING ACTIVITIES:	'	'
Increase in Long-term Debt, Net of Discount	2,182,942	1,983,192
Net Borrowings under Convertible Debt	248,517	'
Proceeds from the Sale of Common Stock	615,000	'
Net Borrowings under Credit Line	25,000	1,594,535
Loans from Related Parties	'	124,454
Net Cash Provided by Financing Activities	3,071,459	3,702,181
Net (Decrease) Increase in Cash and Cash Equivalents	127,165	569,648
Cash and Cash Equivalents at Beginning of Period	498,917	5,112
Cash and Cash Equivalents at End of Period	626,082	574,760
SUPPLEMENTAL CASH FLOW INFORMATION:	'	'
Cash paid during the year for Interest	'	'
Cash paid during the year for Income taxes	'	'

Nature_Of_Operations_And_Going

Nature Of Operations And Going Concern	9 Months Ended
	Mar. 31, 2014
Nature Of Operations And Going Concern	'
Nature Of Operations And Going Concern	'
	NOTE 1 - NATURE OF OPERATIONS AND GOING CONCERN
	Plandaí Biotechnology, Inc.’s (the “Company” or “Plandaí”) consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustment relating to recoverability and classification of recorded amounts of assets and liabilities that might be necessary should the Company be unable to continue as a going concern.
	The Company's continued existence is dependent upon its ability to continue to execute its operating plan and to obtain additional debt or equity financing. There can be no assurance the necessary debt or equity financing will be available, or will be available on terms acceptable to the Company.
	Plandaí and its subsidiaries focus on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries. The company grows much of the live plant material used in its products on a 3,000 hectare estate it operates under a 49-year notarial lease in the Mpumalanga region of South Africa. Plandaí uses a patented extraction process that is designed to yield highly bioavailable products of pharmaceutical-grade purity. The first product to be brought to market is Phytofare™ Catechin Complex, a green-tea derived extract that has multiple potential wellness applications. The company’s principle holdings consist of land, farms and infrastructure in South Africa. The Company is actively pursuing additional financing and has had discussions with various third parties, although no firm commitments have been obtained. Management believes these efforts will generate sufficient cash flows from future operations to pay the Company's obligations and realize positive cash flow. There is no assurance any of these transactions will occur.
	These financial statements should be read in conjunction with the Company’s annual report for the year ended June 30, 2013 previously filed on Form 10-K. In management’s opinion, all adjustments necessary for a fair statement of the results for the interim periods have been made.  All adjustments made were of a normal recurring nature.
	Organization
	On November 17, 2011, the Company, through its wholly-owned subsidiary, Plandaí Biotechnologies, Inc., consummated a share exchange with Global Energy Solutions, Inc. (“GES”), an Irish corporation. Under the terms of the share exchange, GES received 76,000,000 shares of the Company’s common stock that had been previously issued to Plandaí in exchange for 100% of the issued and outstanding capital of GES. Concurrent with the share exchange, the Company sold its subsidiary, Diamond Ranch, Ltd., together with its wholly-owned subsidiary, Executive Seafood, Inc., to a former officer and director of Diamond Ranch. Under the terms of the sale, the purchasers assumed all associated debt as consideration. During the three months ended September 30, 2011 and through the date of the share exchange, Diamond Ranch, Ltd. and Executive Seafood, Inc. had negligible revenues from operations, generated a net loss of $126,000, and as of September 30, 2011, liabilities exceeded assets by over $5,000,000. The Company subsequently changed its name to Plandaí Biotechnology, Inc. and dissolved GES.
	For accounting purposes, the share exchange has been treated as a reverse merger since the acquired entity now forms the basis for operations and the transaction resulted in a change in control, with the acquired company electing to become the successor issuer for reporting purposes. The accompanying financial statements have been prepared to reflect the assets, liabilities and operations of Plandaí Biotechnology, Inc. exclusive of Diamond Ranch Foods since the acquisition and sale were executed simultaneously. For equity purposes, the shares issued to acquire GES (76,000,000 shares) have been shown to be issued and outstanding since inception, with the previous balance outstanding (25,415,300 shares Common) treated as a new issuance as of the date of the share exchange. The additional paid-in capital and retained deficit shown are those of Plandaí and its subsidiary operations.
	In management’s opinion, all adjustments necessary for a fair statement of the results for the presented periods have been made.  All adjustments made were of a normal recurring nature.
	Basis of Presentation
	The Company’s financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The accompanying financial statements represent the consolidated results of operations for the three and nine months ended March 31, 2014.

Summary_Of_Accounting_Policies

Summary Of Accounting Policies	9 Months Ended
	Mar. 31, 2014
Summary Of Accounting Policies	'
Summary Of Accounting Policies	'
	NOTE 2 - SUMMARY OF ACCOUNTING POLICIES
	This summary of accounting policies for Plandaí Biotechnology, Inc. and its wholly-owned subsidiaries, is presented to assist in understanding the Company's financial statements. The accounting policies conform to generally accepted accounting principles and have been consistently applied in the preparation of the financial statements.
	Use of Estimates
	The financial statements are prepared in conformity with accounting principles generally accepted in the United States of America. In preparing the financial statements, management is required to make estimates and assumptions that effect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the balance sheet and statement of operations for the year then ended. Actual results may differ from these estimates. Estimates are used when accounting for allowance for bad debts, collect ability of accounts receivable, amounts due to service providers, depreciation and litigation contingencies, among others.
	Cash and Cash Equivalents
	For purposes of the statement of cash flows, the Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents to the extent the funds are not being held for investment purposes.
	Revenue recognition
	The Company presently derives its revenue from the sale of timber and agricultural products produced on its farm and tea estate holdings in South Africa. Revenue is recognized when the product is delivered to the customer. Once production of the Company’s Phytofare™ botanical extracts commences in 2014, revenues will be recognized when product is shipped.
	Concentration of Credit Risk
	The Company has no significant off-balance sheet concentrations of credit risk such as foreign exchange contracts, options contracts or other foreign hedging arrangements.
	Property and equipment
	Property and equipment are stated at cost less accumulated depreciation and amortization.  The Company provides for depreciation and amortization using the straight-line method over the estimated useful lives of the related assets, which range from three to five years. Maintenance and repair costs are expensed as they are incurred while renewals and improvements which extend the useful life of an asset are capitalized.  At the time of retirement or disposal of property and equipment, the cost and related accumulated depreciation and amortization are removed from the accounts and any resulting gain or loss is reflected in the results of operations.
	Impairment of Long-Lived Assets
	In accordance with ASC Topic 360, formerly SFAS No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets, the Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of these assets may not be fully recoverable. The assessment of possible impairment is based on the Company’s ability to recover the carrying value of its assets based on estimates of its undiscounted future cash flows. If these estimated future cash flows are less than the carrying value of the asset, an impairment charge is recognized for the difference between the asset's estimated fair value and its carrying value. As of the date of these financial statements, the Company is not aware of any items or events that would cause it to adjust the recorded value of its long-lived assets for impairment.
	Earnings per Share
	Basic gain or loss per share has been computed by dividing the loss for the period applicable to the common stockholders by the weighted average number of common shares outstanding during the years. At March 31, 2014, the Company had one convertible debenture outstanding that if-converted would result in 673,741 new common shares being issued. At June 30, 2013, the Company had one convertible debenture outstanding that if-converted would result in 340,984 new common shares being issued.
	Income Taxes
	The Company accounts for income taxes under ASC Topic 740, formerly SFAS No. 109, Accounting for Income Taxes, as clarified by ASC Topic 740, formerly FASB Interpretation No. 48, Accounting for Uncertainty in Income Taxes, (“FIN No. 48”). Deferred tax assets and liabilities are determined based upon differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized.
	The Company adopted the provisions of ASC Topic 740, formerly FIN No. 48 on January 1, 2007. Previously, the Company had accounted for tax contingencies in accordance with Statement of Financial Accounting Standards No. 5, Accounting for Contingencies. As required by ASC Topic 450, formerly FIN No. 48, the Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority. At the adoption date, the Company applied ASC Topic 740, formerly FIN No. 48 to all tax positions for which the statute of limitations remained open. As a result of the implementation of ASC Topic 740, formerly FIN No. 48, the Company did not recognize any change in the liability for unrecognized tax benefits.
	The Company is subject to income taxes in the U.S. federal jurisdiction and that of South Africa. Tax regulations within each jurisdiction are subject to the interpretation of the related tax laws and regulations and require significant judgment to apply. With few exceptions, the Company is no longer subject to U.S. federal, state and local income tax examinations by tax authorities for the years before April 1, 2007.
	The Company is not currently under examination by any federal or state jurisdiction.
	The Company’s policy is to record tax-related interest and penalties as a component of operating expenses.
	Off-Balance Sheet Arrangements
	We have no off-balance sheet arrangements.
	Emerging Growth Company
	We qualify as an “emerging growth company” under the 2012 JOBS Act. Section 107 of the JOBS Act provides that an emerging growth company can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. As an emerging growth company, we can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to take advantage of the benefits of this extended transition period.
	Fair Value of Financial Instruments
	Fair value of certain of the Company’s financial instruments including cash and cash equivalents, accounts receivable, account payable, accrued expenses, notes payables, and other accrued liabilities approximate cost because of their short maturities. The Company measures and reports fair value in accordance with ASC 820, “Fair Value Measurements and Disclosure” defines fair value, establishes a framework for measuring fair value in accordance with generally accepted accounting principles and expands disclosures about fair value investments.
	Fair value, as defined in ASC 820, is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value of an asset should reflect its highest and best use by market participants, principal (or most advantageous) markets, and an in-use or an in-exchange valuation premise. The fair value of a liability should reflect the risk of nonperformance, which includes, among other things, the Company’s credit risk.
	Valuation techniques are generally classified into three categories: the market approach; the income approach; and the cost approach. The selection and application of one or more of the techniques may require significant judgment and are primarily dependent upon the characteristics of the asset or liability, and the quality and availability of inputs. Valuation techniques used to measure fair value under ASC 820 must maximize the use of observable inputs and minimize the use of unobservable inputs. ASC 820 also provides fair value hierarchy for inputs and resulting measurement as follows:
	Level 1
	Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities; The Company values it’s available for sale securities using Level 1.
	Level 2
	Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities; and
	Level 3
	Unobservable inputs for the asset or liability that are supported by little or no market activity and that are significant to the fair values.
	Fair value measurements are required to be disclosed by the Level within the fair value hierarchy in which the fair value measurements in their entirety fall. Fair value measurements using significant unobservable inputs (in Level 3 measurements) are subject to expanded disclosure requirements including a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (i) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings, and a description of where those gains or losses included in earning are reported in the statement of income.
	Advertising
	Advertising costs are expensed as incurred.
	Principles of Consolidation
	Plandaí Biotechnology, Inc. and its subsidiaries, are encompassed in the following entities, which have been consolidated in the accompanying financial statements:
	Cannabis Biosciences, Inc.	100% owned by Plandaí Biotechnology, Inc.
	Phyto Nutricare, Inc.	100% owned by Plandaí Biotechnology, Inc.
	Phyto Pharmacare, Inc.	100% owned by Plandaí Biotechnology, Inc.
	Dunn Roman Holdings—Africa, Ltd	100% owned by Plandaí Biotechnology, Inc.
	Breakwood Trading 22 (Pty) Ltd.	74% owned by Dunn Roman Holdings-Africa
	Green Gold Biotechnologies (Pty) Ltd.	84% owned by Dunn Roman Holdings-Africa
	During the year ended June 30, 2013, the Company determined that the entity, Global Energy Solutions, was unnecessary to operations and decided to dissolve that corporation, resulting in the stock of Dunn Roman Holdings-Africa being held directly by Plandaí. All liabilities were either satisfied or forgiven and all bank accounts closed. There were no operations in Global Energy Solutions during the periods presented. Global Energy Solutions was officially dissolved during the year ended June 30, 2013.
	All intercompany balances have been eliminated in consolidation.
	Straight-lining of Lease Obligation
	Plandaí’s subsidiaries have two long-term, material leases which either have escalating terms or include several months of “free” rent, including the 49-year notarial lease for the Senteeko Tea Estate. In accordance with US Generally Accepted Accounting Principles, the Company has calculated a straight-line monthly cost on the leases and recorded the corresponding difference between the amount actually paid and the amount calculated as a Capitalized Lease Obligation. As of March 31, 2014, the amount of this deferred liability was $1,290,341.
	Recent Accounting Pronouncements
	Recent accounting pronouncements that the Company has adopted or that will be required to adopt in the future are summarized below.
	All recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA, and the SEC did not or are not believed by management to have a material impact on the Company's present or future financial statements.

Loans_From_Related_Parties

Loans From Related Parties	9 Months Ended
	Mar. 31, 2014
Loans From Related Parties	'
Loans From Related Parties	'
	NOTE 3 - LOANS FROM RELATED PARTIES
	As of March 31, 2014, the Company had an outstanding loans from a director in the amount of $12,186, which represented unpaid reimbursement of office expenses, including rent, from prior periods. During the quarter ended March 31, 2014, the company converted $482,958 payable to the Company’s Chief Executive Officer into 2,036,000 shares of restricted common stock, which represented the fair value of the shares on the date of conversion.

Line_Of_Credit

Line Of Credit	9 Months Ended
	Mar. 31, 2014
DisclosurePrepaidExpensesAbstract	'
Line of Credit	'
	NOTE 4 - LINE OF CREDIT
	During the year ended June 30, 2012, the company entered into a line of credit agreement for $500,000 which was later increased to $1,000,000. The line of credit matures on January 5, 2014 and bears interest at the rate of ten percent (10%) per annum. As of December 31, 2013, the balance drawn down on the credit line was $777,503 and accrued interest was $104,997. On December 31, 2013, the company converted the balance outstanding plus accrued interest into 5,000,000 shares of restricted common stock.

Debenture_Payable

Debenture Payable	9 Months Ended
	Mar. 31, 2014
Debt Disclosure [Abstract]	'
Debenture Payable	'
	NOTE 5 - DEBENTURE PAYABLE
	In May 2013, the Company issued an 8% interest rate convertible debenture in the amount of $103,500 which becomes due and payable in February 2014. The debenture is convertible into common stock of the Company at a discount of 42% off the market price of the Company’s common stock six months after issuance (November 2013). The Company repaid the debenture in full on November 11, 2013.
	On August 20, 2013, the Company executed two convertible promissory notes totaling $550,000. The notes bear interest at the rate of 8% per annum and become due and payable six months from the date of issuance. During the first 90 days from issuance, the notes are repayable without incurring any interest charges. The Company was advanced $210,000 against the two notes. During the quarter ended March 31, 2014, $149,729 of the unpaid principal plus accrued interest was converted into 2,717,035 shares of restricted common stock.
	On November 13, 2013, the Company executed a convertible promissory note of $113,500, which included prepaid interest of $10,000. The note bore interest at 10% per annum and was due and payable twelve months from the date of issuance. At the holder’s option, the unpaid principal and interest was convertible into common stock at a 42% discount to market after six months. During the quarter ended March 31, 2014, the Company repaid the debenture and all associated interest.
	The Company has recorded a derivative liability of $352,120 as of March 31, 2014 representing the estimate value of the shares over and above the amount of debentures that would be issued on conversion. During the nine months ended March 31, 2014, the Company recorded $2,086,436 as derivative interest expense which was then offset against additional paid in capital when the debentures were converted.

Long_Term_Debt

Long Term Debt	9 Months Ended
	Mar. 31, 2014
Long Term Debt	'
Long Term Debt	'
	NOTE 6 - LONG-TERM DEBT
	In June 2012, the Company, through the majority-owned subsidiaries of Dunn Roman Holdings, Inc., executed final loan documents on a 100 million Rand (approx. $13 million USD) financing with the Land and Agriculture Bank of South Africa. The total loan is comprised of multiple agreements totaling, between Green Gold Biotechnologies (Pty) Ltd. and Breakwood Trading 22(Pty) Ltd., 100 million rand. The loans all bear interest at the rate of prime plus 0.5% per annum and are all due in seven years. In addition, the loans have a 25-month “holiday” in which no payments or interest are due until 25 months after the first drawn down of funds. The loans are collateralized by the assets and operations, including the Senteeko lease, agriculture production and receivables of Dunn Roman Holdings, which is the African operating arm of Plandaí. In addition, Dunn Roman Holdings was required to grant a 15% profit share agreement to the Land Bank which extends through the duration of the loan agreements (7 years unless pre-paid). The profit share agreement extends only to profits generated by Dunn Roman Holdings exclusive of operations of Plandaí and outside of South Africa. By way of loan covenants, the borrowing entities are required to maintain a debt to equity ratio of 1.5:1, interest coverage ratio of 1.5:1, and security coverage ratio of 1:1. The Company notified the Land Bank that these covenants have been out of compliance since the inception of the loan and subsequently received a letter from the Land Bank which suspends these loan covenants.
	As of March 31, 2014, a total of $8,414,166 had been drawn down against the loans by Green Gold Biotechnologies (Pty) Ltd., which was used to purchase fixed assets that will be employed in South Africa to produce the company’s botanical extracts. Additionally, $2,327,479 had been drawn down against the loans by Breakwood Trading22 (Pty) Ltd. to fund the rehabilitation of the Senteeko Tea Estate, including the repair of roads, bridges, and onsite worker housing, and the pruning, weeding and fertilizing of plantation.
	During the year ended June 30, 2012, the Company issued 1,500,000 shares of restricted common stock to three individuals in exchange for shares of Dunn Roman Holdings stock which had been previously issued. The acquired Dunn Roman shares were then provided to thirds parties in order to comply with the BEE provisions associated with the loan from the Land Bank of South Africa, which required that 15% of Dunn Roman be black owned. The Company has therefore determined to treat the value of the shares issued to acquire the Dunn Roman stock ($585,000) as a cost of securing the financing and recorded as a loan discount which will be amortized over the life of the loan (7 years) once payment of the loan commences in July 2014.
	As of March 31, 2014, the loan balance was:
	Loan Principal	$	10,741,645
	Less: Discount		585,000
	Net Loan per Books		10,156,645
	During the quarter ended December 31, 2013, the company borrowed $250,000 from an unrelated third party. The note bears interest at 6% per annum and is due June 30, 2015. During the quarter ended March 31, 2014, the company borrowed and additional $950,000 from this same entity and under identical terms.

Currency_Adjustment

Currency Adjustment	9 Months Ended
	Mar. 31, 2014
Currency Adjustment	'
Currency Adjustment	'
	NOTE 7 - CURRENCY ADJUSTMENT
	The Company’s principal operations are located in South Africa and the primary currency used is the South African Rand. Accordingly, the financial statements are first prepared in using Rand and then converted to US Dollars for reporting purposes, with the average conversion rate being used for income statement purposes and the closing exchange rate as of March 31, 2014 applied to the balance sheet. Differences resulting from the fluctuation in the exchange rate are recorded as an offset to equity in the balance sheet. As of March 31, 2014, the cumulative currency translation adjustments were $311,115.

Fixed_Assets

Fixed Assets	9 Months Ended
	Mar. 31, 2014
Property, Plant and Equipment [Abstract]	'
Fixed Assets	'
	NOTE 8 - FIXED ASSETS
	Fixed assets, stated at cost, less accumulated depreciation at March 31, 2014 consisted of the following:
		March 31,
		2014
	Total Fixed Assets	$	9,138,608
	Less: Accumulated Depreciation		(244,922	)
	Fixed Assets, net	$	8,893,686
	Depreciation expense
	Depreciation expense for the three and nine months ended March 31, 2014 was $43,744 and $142,808, respectively.

Common_Stock

Common Stock	9 Months Ended
	Mar. 31, 2014
DisclosureCommonStockAbstract	'
Common Stock	'
	NOTE 9 - COMMON STOCK
	During the nine months ended March 31, 2014, the Company engaged in the following common stock transactions:
		•	A total of 1,230,033 shares of restricted common stock were issued in exchange for proceeds of $615,000.
		•	A total of 250,000 shares that had been issued in prior periods for services previously rendered were cancelled.
		•	A total of 5,000,000 shares of restricted common stock were issued in satisfaction of a credit line and accrued interest totaling $882,500.
		•	A total of 2,717,035 shares of restricted common stock were issued in satisfaction of convertible debentures and associated interest totaling $149,729.
		•	A total of 2,036,0000 shares of restricted common stock were issued in satisfaction of a note payable of $499,797 to the company’s Chief Executive Officer.
		•	A total of 9,380,000 shares of restricted common stock were issued for services previously rendered, which included $261,000 in services from the prior year which had been recorded as Stock Subscription Payable as of June 30, 2013.
		•	A total of 1,100,000 shares of restricted common stock were issued to acquire 15% interest in Dunn Roman Holdings and 10% interest in Green Gold Biotechnologies, both of which were, at the time of the transaction, majority owned subsidiaries of the Company.
		•	On February 4, 2014, the Company closed on an agreement to acquire the license to the intellectual property and trade name associated with “Diego Pellicer.” Under the terms of the agreement, the Company granted warrants to purchase 5,000,000 shares of the Company’s stock at a purchase price of $0.01 per share.
		•	On February 4, 2014, the Company executed an stock purchase agreement in the amount of $15,300,000 which permits the Company to sell shares, at its option generally based on current market prices for the 30 month period commencing upon the execution of the stock purchase agreement, subject to the registration of resale of the underlying shares with the Securities and Exchange Commission. The Company received $300,000 in proceeds under the agreement in exchange for 480,000 shares of restricted common stock sold upon the execution of the stock purchase agreement. An additional 540,000 shares of restricted common stock were issued as consideration for executing the Agreement. The value of the shares on the date of issuance, $459,000, has been treated as financing costs.

NonControlling_Interest

Non-Controlling Interest	9 Months Ended
	Mar. 31, 2014
Non-Controlling Interest	'
Non-Controlling Interest	'
	NOTE 10 - NON-CONTROLLING INTEREST
	Plandaí owns 100% of Dunn Roman Holdings—Africa, which in turn owns 74% of Breakwood Trading 22 (Pty), Ltd. and 84% of Green Gold Biotechnologies (Pty), Ltd., in order to be compliant with the Black Economic Empowerment rules imposed by the South African Land Bank. While the Company, under the Equity Method of Accounting, is required to consolidate 100% of the operations of its majority-owned subsidiaries, that portion of subsidiary net equity attributable to the non-controlling ownership, together with an allocated portion of net income or net loss incurred by the subsidiaries, must be reflected on the consolidated financial statements. On the balance sheet, non-controlling interest has been shown in the Equity Section, separated from the equity of Plandaí, while on the income statement, the non-controlling shareholder allocation of net loss has been shown in the Consolidated Statement of Operations.

Capitalized_Lease_Obligations

Capitalized Lease Obligations	9 Months Ended
	Mar. 31, 2014
Capitalized Lease Obligations	'
Capitalized Lease Obligation	'
	NOTE 11 - CAPITALIZED LEASE OBLIGATIONS
	In February 2012, the Company entered into a long-term (49 year) lease of tea, avocado, macadamia and timber plantation estates totaling roughly eight thousand acres in South Africa. Under the terms of the lease, the Company is required to pay annual rent of R250,000 ($30,000) plus an annual dividend of 26% of net income generated from the use of the property with a R500,000 ($60,000) annual minimum dividend. The first payment of R20,883 ($2,610) was due April 2012, but by mutual agreement this payment was extended until funding is received under the loan from the Land Bank of South Africa. On March 1, 2012, the Company entered into a 10 year lease for office space for its subsidiary Dunn Roman Holdings. Under the terms of the lease, payments are $2,500 a month.
	Both of these leases either have escalating terms or included several months of “free” rent, including the 49-year notarial lease for the Senteeko Tea Estate. In accordance with US Generally Accepted Accounting Principles, the Company has calculated a straight-line monthly cost on the leases and recorded the corresponding difference between the amount actually paid and the amount calculated as a Capitalized Lease Obligation. As of March 31, 2014, the amount of this deferred liability was $1,290,341.

Related_Party_Transaction

Related Party Transaction	9 Months Ended
	Mar. 31, 2014
Related Party Transaction	'
Related Party Transaction	'
	NOTE 12 - RELATED PARTY TRANSACTION
	In addition to the loans payable and receivables as discussed above, the Company had the following related party transactions during the nine months ended March 31, 2014.
	Compensation to Officers and Management
	Pursuant to three employment agreements executed on March 1, 2013 by the Company with two of its officers and one manager, the Company is also obligated to issue 4,000,000 common shares at the end of each completed year for services rendered to the Company. The Company valued the 4,000,000 shares at the closing stock price on the date of the executed agreement which was $0.06 per share. At December 31, 2013, the Company accrued compensation expense for services completed in the amount of $1,056,600, which was been recorded as Stock Subscription Payable. In January 2014, the Company issued a total of 8,000,000 shares of common stock under these agreements to satisfy its obligations for the service years ended March 1, 2013 and March 31 2014.

Subsequent_Events

Subsequent Events	9 Months Ended
	Mar. 31, 2014
Subsequent Events	'
Subsequent Events	'
	NOTE 13 - SUBSEQUENT EVENTS
	Management has evaluated subsequent events pursuant to the requirements of ASC Topic 855 and has determined that no material subsequent events exist through the date of this filing.

Summary_Of_Accounting_Policies1

Summary Of Accounting Policies (Policies)	9 Months Ended
	Mar. 31, 2014
Summary Of Accounting Policies Policies	'
Use Of Estimates	'
	Use of Estimates
	The financial statements are prepared in conformity with accounting principles generally accepted in the United States of America. In preparing the financial statements, management is required to make estimates and assumptions that effect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the balance sheet and statement of operations for the year then ended. Actual results may differ from these estimates. Estimates are used when accounting for allowance for bad debts, collect ability of accounts receivable, amounts due to service providers, depreciation and litigation contingencies, among others.
Cash And Cash Equivalents	'
	Cash and Cash Equivalents
	For purposes of the statement of cash flows, the Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents to the extent the funds are not being held for investment purposes.
Revenue Recognition	'
	Revenue recognition
	The Company presently derives its revenue from the sale of timber and agricultural products produced on its farm and tea estate holdings in South Africa. Revenue is recognized when the product is delivered to the customer. Once production of the Company’s Phytofare™ botanical extracts commences in 2014, revenues will be recognized when product is shipped.
Concentration Of Credit Risk	'
	Concentration of Credit Risk
	The Company has no significant off-balance sheet concentrations of credit risk such as foreign exchange contracts, options contracts or other foreign hedging arrangements.
Property And Equipment	'
	Property and equipment
	Property and equipment are stated at cost less accumulated depreciation and amortization.  The Company provides for depreciation and amortization using the straight-line method over the estimated useful lives of the related assets, which range from three to five years. Maintenance and repair costs are expensed as they are incurred while renewals and improvements which extend the useful life of an asset are capitalized.  At the time of retirement or disposal of property and equipment, the cost and related accumulated depreciation and amortization are removed from the accounts and any resulting gain or loss is reflected in the results of operations.
Impairment Of Long-Lived Assets	'
	Impairment of Long-Lived Assets
	In accordance with ASC Topic 360, formerly SFAS No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets, the Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of these assets may not be fully recoverable. The assessment of possible impairment is based on the Company’s ability to recover the carrying value of its assets based on estimates of its undiscounted future cash flows. If these estimated future cash flows are less than the carrying value of the asset, an impairment charge is recognized for the difference between the asset's estimated fair value and its carrying value. As of the date of these financial statements, the Company is not aware of any items or events that would cause it to adjust the recorded value of its long-lived assets for impairment.
Earnings Per Share	'
	Earnings per Share
	Basic gain or loss per share has been computed by dividing the loss for the period applicable to the common stockholders by the weighted average number of common shares outstanding during the years. At March 31, 2014, the Company had one convertible debenture outstanding that if-converted would result in 673,741 new common shares being issued. At June 30, 2013, the Company had one convertible debenture outstanding that if-converted would result in 340,984 new common shares being issued.
Income Taxes	'
	Income Taxes
	The Company accounts for income taxes under ASC Topic 740, formerly SFAS No. 109, Accounting for Income Taxes, as clarified by ASC Topic 740, formerly FASB Interpretation No. 48, Accounting for Uncertainty in Income Taxes, (“FIN No. 48”). Deferred tax assets and liabilities are determined based upon differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized.
	The Company adopted the provisions of ASC Topic 740, formerly FIN No. 48 on January 1, 2007. Previously, the Company had accounted for tax contingencies in accordance with Statement of Financial Accounting Standards No. 5, Accounting for Contingencies. As required by ASC Topic 450, formerly FIN No. 48, the Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority. At the adoption date, the Company applied ASC Topic 740, formerly FIN No. 48 to all tax positions for which the statute of limitations remained open. As a result of the implementation of ASC Topic 740, formerly FIN No. 48, the Company did not recognize any change in the liability for unrecognized tax benefits.
	The Company is subject to income taxes in the U.S. federal jurisdiction and that of South Africa. Tax regulations within each jurisdiction are subject to the interpretation of the related tax laws and regulations and require significant judgment to apply. With few exceptions, the Company is no longer subject to U.S. federal, state and local income tax examinations by tax authorities for the years before April 1, 2007.
	The Company is not currently under examination by any federal or state jurisdiction.
	The Company’s policy is to record tax-related interest and penalties as a component of operating expenses.
Off-Balance Sheet Arrangements	'
	Off-Balance Sheet Arrangements
	We have no off-balance sheet arrangements.
Emerging Growth Company	'
	Emerging Growth Company
	We qualify as an “emerging growth company” under the 2012 JOBS Act. Section 107 of the JOBS Act provides that an emerging growth company can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. As an emerging growth company, we can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to take advantage of the benefits of this extended transition period.
Fair Value Of Financial Instruments	'
	Fair Value of Financial Instruments
	Fair value of certain of the Company’s financial instruments including cash and cash equivalents, accounts receivable, account payable, accrued expenses, notes payables, and other accrued liabilities approximate cost because of their short maturities. The Company measures and reports fair value in accordance with ASC 820, “Fair Value Measurements and Disclosure” defines fair value, establishes a framework for measuring fair value in accordance with generally accepted accounting principles and expands disclosures about fair value investments.
	Fair value, as defined in ASC 820, is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value of an asset should reflect its highest and best use by market participants, principal (or most advantageous) markets, and an in-use or an in-exchange valuation premise. The fair value of a liability should reflect the risk of nonperformance, which includes, among other things, the Company’s credit risk.
	Valuation techniques are generally classified into three categories: the market approach; the income approach; and the cost approach. The selection and application of one or more of the techniques may require significant judgment and are primarily dependent upon the characteristics of the asset or liability, and the quality and availability of inputs. Valuation techniques used to measure fair value under ASC 820 must maximize the use of observable inputs and minimize the use of unobservable inputs. ASC 820 also provides fair value hierarchy for inputs and resulting measurement as follows:
	Level 1
	Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities; The Company values it’s available for sale securities using Level 1.
	Level 2
	Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities; and
	Level 3
	Unobservable inputs for the asset or liability that are supported by little or no market activity and that are significant to the fair values.
	Fair value measurements are required to be disclosed by the Level within the fair value hierarchy in which the fair value measurements in their entirety fall. Fair value measurements using significant unobservable inputs (in Level 3 measurements) are subject to expanded disclosure requirements including a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (i) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings, and a description of where those gains or losses included in earning are reported in the statement of income.
Advertising	'
	Advertising
	Advertising costs are expensed as incurred.
Principles of Consolidation	'
	Principles of Consolidation
	Plandaí Biotechnology, Inc. and its subsidiaries, are encompassed in the following entities, which have been consolidated in the accompanying financial statements:
	Cannabis Biosciences, Inc.	100% owned by Plandaí Biotechnology, Inc.
	Phyto Nutricare, Inc.	100% owned by Plandaí Biotechnology, Inc.
	Phyto Pharmacare, Inc.	100% owned by Plandaí Biotechnology, Inc.
	Dunn Roman Holdings—Africa, Ltd	100% owned by Plandaí Biotechnology, Inc.
	Breakwood Trading 22 (Pty) Ltd.	74% owned by Dunn Roman Holdings-Africa
	Green Gold Biotechnologies (Pty) Ltd.	84% owned by Dunn Roman Holdings-Africa
	During the year ended June 30, 2013, the Company determined that the entity, Global Energy Solutions, was unnecessary to operations and decided to dissolve that corporation, resulting in the stock of Dunn Roman Holdings-Africa being held directly by Plandaí. All liabilities were either satisfied or forgiven and all bank accounts closed. There were no operations in Global Energy Solutions during the periods presented. Global Energy Solutions was officially dissolved during the year ended June 30, 2013.
	All intercompany balances have been eliminated in consolidation.
Straight-lining of Lease Obligation	'
	Straight-lining of Lease Obligation
	Plandaí’s subsidiaries have two long-term, material leases which either have escalating terms or include several months of “free” rent, including the 49-year notarial lease for the Senteeko Tea Estate. In accordance with US Generally Accepted Accounting Principles, the Company has calculated a straight-line monthly cost on the leases and recorded the corresponding difference between the amount actually paid and the amount calculated as a Capitalized Lease Obligation. As of March 31, 2014, the amount of this deferred liability was $1,290,341.
Recent Accounting Pronouncements	'
	Recent Accounting Pronouncements
	Recent accounting pronouncements that the Company has adopted or that will be required to adopt in the future are summarized below.
	All recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA, and the SEC did not or are not believed by management to have a material impact on the Company's present or future financial statements.

Long_Term_Debt_Tables

Long Term Debt (Tables)	9 Months Ended
	Mar. 31, 2014
Long Term Debt Tables	'
Schedule Of Long Term Debt	'
	As of March 31, 2014, the loan balance was:
	Loan Principal	$	10,741,645
	Less: Discount		585,000
	Net Loan per Books		10,156,645

Fixed_Assets_Tables

Fixed Assets (Tables)	9 Months Ended
	Mar. 31, 2014
Fixed Assets Tables	'
Schedule Of Fixed Assets	'
	Fixed assets, stated at cost, less accumulated depreciation at March 31, 2014 consisted of the following:
		March 31,
		2014
	Total Fixed Assets	$	9,138,608
	Less: Accumulated Depreciation		(244,922	)
	Fixed Assets, net	$	8,893,686

Long_Term_Debt_Details

Long Term Debt (Details) (USD $)	Mar. 31, 2014
Long Term Debt Details	'
Loan Principle	$10,741,645
Less: Discount	585,000
Net Loan Per books	$10,156,645

Fixed_Assets_Details

Fixed Assets (Details) (USD $)	Mar. 31, 2014	Jun. 30, 2013
Fixed Assets Details	'	'
Total Fixed Assets	$9,138,608	'
Less: Accumulated Depreciation	244,922	'
Fixed Assets, net	$8,893,686	$7,924,910

Nature_Of_Operations_And_Going1

Nature Of Operations And Going Concern (Narrative) (Details) (USD $)	0 Months Ended	12 Months Ended	3 Months Ended
	Nov. 17, 2011	Jun. 30, 2012	Sep. 30, 2011
	Global Energy Solutions, Inc (GES)	Global Energy Solutions, Inc (GES)	Diamond Ranch Ltd And Executive Seafood Inc
Net loss	'	'	$126,000
Name of acquired entity	'Global Energy Solutions, Inc. ("GES"), an Irish corporation	'	'
Percentage of ownership acquired	100.00%	'	'
Excess of liabilities over assets taken over	'	'	$5,000,000
Shares issued to GES	76,000,000	25,415,300	'

Summary_Of_Accounting_Policies2

Summary Of Accounting Policies (Narrative) (Details)	9 Months Ended	12 Months Ended
	Mar. 31, 2014	Jun. 30, 2013
Property, Plant and Equipment [Line Items]	'	'
Antidilutive securities excluded from computation of earnings per share	'	340,984
Shares issued for conversion, shares	673,741	'
Cannabis Biosciences, Inc	'	'
Property, Plant and Equipment [Line Items]	'	'
Holding by Plandai Biotechnology Inc	100.00%	'
Phyto Nutricare, Inc	'	'
Property, Plant and Equipment [Line Items]	'	'
Holding by Plandai Biotechnology Inc	100.00%	'
Phyto Pharmacare, Inc	'	'
Property, Plant and Equipment [Line Items]	'	'
Holding by Plandai Biotechnology Inc	100.00%	'
Dunn Roman Holdings-Africa, Ltd	'	'
Property, Plant and Equipment [Line Items]	'	'
Holding by Plandai Biotechnology Inc	100.00%	'
Breakwood Trading 22 (Pty) Ltd	'	'
Property, Plant and Equipment [Line Items]	'	'
Holding by Dunn Roman Holdings-Africa	74.00%	'
Green Gold Biotechnologies (Pty) Ltd	'	'
Property, Plant and Equipment [Line Items]	'	'
Holding by Dunn Roman Holdings-Africa	84.00%	'
Minimum	'	'
Property, Plant and Equipment [Line Items]	'	'
Property and equipment estimated useful life	'3 years	'
Maximum	'	'
Property, Plant and Equipment [Line Items]	'	'
Property and equipment estimated useful life	'5 years	'

Loans_From_Related_Parties_Nar

Loans From Related Parties (Narrative) (Details) (USD $)	Mar. 31, 2014	Jun. 30, 2013	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2014
			Convertible Notes Payable	Restricted Common Stock	Restricted Common Stock
			Chief Executive Officer	Convertible Notes Payable	Convertible Notes Payable
				Chief Executive Officer	Chief Executive Officer
Debt Instrument [Line Items]	'	'	'	'	'
Loans from Related Parties	'	$501,518	$12,186	'	'
Stock issued in conversion of debt, shares	'	'	'	2,036,000	20,360,000
Stock issued in conversion of debt, value	'	'	'	$482,958	$499,797

Line_Of_Credit_Narrative_Detai

Line Of Credit (Narrative) (Details) (USD $)	Mar. 31, 2014	Jun. 30, 2013	Jun. 30, 2012	Dec. 31, 2013
			Line Of Credit	Line Of Credit
Line of Credit Facility [Line Items]	'	'	'	'
Line of credit available at the time of entering into agreement	'	'	$500,000	'
Line of credit increase during the period	'	'	1,000,000	'
Line of credit maturity date	'	'	5-Jan-14	'
Interest rate on line of credit	'	'	10.00%	'
Accrued interest	22,570	93,184	'	104,997
Line of credit	'	$752,503	'	$777,503

Debenture_Payable_Narrative_De

Debenture Payable (Narrative) (Details) (USD $)	9 Months Ended		1 Months Ended	0 Months Ended		3 Months Ended	0 Months Ended
	Mar. 31, 2014	Jun. 30, 2013	31-May-13	Aug. 20, 2013	Dec. 31, 2013	Mar. 31, 2014	Nov. 13, 2013
			Convertible Notes Payable	Two Convertible Promissory Notes	Two Convertible Promissory Notes	Two Convertible Promissory Notes	Convertible Promissory Note - November 13, 2013
						Restricted Common Stock
Debt Instrument [Line Items]	'	'	'	'	'	'	'
Debt instrument face amount	'	'	$103,500	$550,000	'	'	$113,500
Debt instrument interest rate	'	'	8.00%	8.00%	'	'	10.00%
Debt instrument conversion terms	'	'	'The debenture is convertible into common stock of the company at a discount of 42% off the market price of the company's common stock six months after issuance (November 2013).	'	'	'	'
Debt instrument maturity description	'	'	'February 2014	'	'	'	'
Debt instrument term	'	'	'	'6 months	'	'	'12 months
Debt repayment terms	'	'	'	'	'	'	'
				During the first 90 days from issuance, the notes are repayable without incurring any interest charges.
Convertible note payable	73,480	103,500	'	'	210,000	'	'
Prepaid interest	'	'	'	'	'	'	10,000
Derivative interest expenses	2,086,436	'	'	'	'	'	'
Derivative liability	352,120	'	'	'	'	'	'
Stock issued in conversion of debt, shares	'	'	'	'	'	2,717,035	'
Stock issued in conversion of debt, value	'	'	'	'	'	$149,729	'

Long_Term_Debt_Narrative_Detai

Long Term Debt (Narrative) (Details)	9 Months Ended		1 Months Ended	0 Months Ended				3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Jun. 30, 2012	Jun. 30, 2012	Mar. 31, 2014	Mar. 31, 2014	Jun. 30, 2012	Mar. 31, 2014	Dec. 31, 2013
	USD ($)	USD ($)	Loan - Land And Agriculture Bank Of South Africa	Loan - Land And Agriculture Bank Of South Africa	Loan - Land And Agriculture Bank Of South Africa	Loan - Land And Agriculture Bank Of South Africa	Loan - Land And Agriculture Bank Of South Africa	Loan From Unrelated Third Party	Loan From Unrelated Third Party
			USD ($)	Restricted Common Stock	Green Gold Biotechnologies (Pty) Ltd	Breakwood Trading 22 (Pty) Ltd	South Africa, Rand	USD ($)	USD ($)
				Director of Dunn Roman Holding, Ltd	USD ($)	USD ($)	ZAR
Debt instrument face amount	'	'	$13,000,000	'	'	'	100,000,000	'	$250,000
Interest rate on loan	'	'	'Prime plus 0.50 % per annum	'	'	'	'	'	'
Loan duration	'	'	'7 years	'	'	'	'	'	'
Loans executed through	'	'	'Green Gold Biotechnologies (Pty) Ltd and Breakwood Trading 22(Pty) Ltd	'	'	'	'	'	'
Loan description	'	'	'	'	'	'	'	'	'
			In addition, the loans have a 25-month “holiday” in which no payments or interest are due until 25 months after the first drawn down of funds. The loans are collateralized by the assets and operations, including the Senteeko lease, agriculture production and receivables of Dunn Roman Holdings, which is the African operating arm of Plandaí. In addition, Dunn Roman Holdings was required to grant a 15% profit share agreement to the Land Bank which extends through the duration of the loan agreements (7 years unless pre-paid). The profit share agreement extends only to profits generated by Dunn Roman Holdings exclusive of operations of Plandaí and outside of South Africa.	The acquired Dunn Roman shares were then provided to thirds parties in order to comply with the BEE provisions associated with the loan from the Land Bank of South Africa, which required that 15% of Dunn Roman be black owned. The Company has therefore determined to treat the value of the shares issued to acquire the Dunn Roman stock ($585,000) as a cost of securing the financing and recorded as a loan discount which will be amortized over the life of the loan (7 years) once payment of the loan commences in July 2014.
Loan covenants description	'	'	'	'	'	'	'	'	'
			By way of loan covenants, the borrowing entities are required to maintain a debt to equity ratio of 1.5:1, interest coverage ratio of 1.5:1, and security coverage ratio of 1:1.
Amount drawn against loan	10,741,645	'	'	'	8,414,166	2,327,479	'	'	'
Debt instrument interest rate	'	'	'	'	'	'	'	'	6.00%
Debt instrument maturity date	'	'	'	'	'	'	'	'	30-Jun-15
Shares issued of restricted common stock	'	'	'	1,500,000	'	'	'	'	'
Proceeds from debt	$2,182,942	$1,983,192	'	'	'	'	'	$950,000	'

Common_Stock_Narrative_Details

Common Stock (Narrative) (Details) (USD $)

9 Months Ended

0 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2014

Feb. 04, 2014

Feb. 04, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Dunn Roman Holdings

Green Gold Biotechnologies

License Agreement - Diego Pellicer

Restricted Common Stock

Restricted Common Stock

Restricted Common Stock

Restricted Common Stock

Restricted Common Stock

Restricted Common Stock

Restricted Common Stock

Restricted Common Stock

Share issued to Dunn Roman Holding and Green Gold Biotechnologies

Stock Subscription Payable

Line Of Credit

Two Convertible Promissory Notes

Convertible Notes Payable

Convertible Notes Payable

Chief Executive Officer

Chief Executive Officer

Stock issued during period for cash, shares

'

'

'

'

'

'

1,230,033

'

'

'

'

'

'

Proceeds from sale of common stock

$615,000

'

'

'

'

$300,000

$615,000

'

'

'

'

'

'

Cancellation of shares issued for services, shares

'

'

'

'

'

'

250,000

'

'

'

'

'

'

Stock issued in conversion of debt, shares

'

'

'

'

'

'

'

'

9,380,000

5,000,000

2,717,035

2,036,000

20,360,000

Stock issued in conversion of debt, value

'

'

'

'

'

'

'

'

$261,000

$882,500

$149,729

$482,958

$499,797

Shares issued for stock purchase agreement, shares

'

'

'

'

'

480,000

'

'

'

'

'

'

'

Additional shares issued for consideration

'

'

'

'

'

540,000

'

'

'

'

'

'

'

Stock purchase agreement description

'

'

'

'

'

'

'

'

'

'

'

'

'

Under the terms of the agreement, the Company granted warrants to purchase 5,000,000 shares of the Company’s stock at a purchase price of $0.01 per share.

On February 4, 2014, the Company executed an stock purchase agreement in the amount of $15,300,000 which permits the Company to sell shares, at its option generally based on current market prices for the 30 month period commencing upon the execution of the stock purchase agreement, subject to the registration of resale of the underlying shares with the Securities and Exchange Commission.

Share issued to subsidiaries

'

'

'

'

'

'

'

1,100,000

'

'

'

'

'

Percentage of ownership acquired

'

'

15.00%

10.00%

'

'

'

'

'

'

'

'

'

Capitalized_Lease_Obligations_

Capitalized Lease Obligations (Narrative) (Details)	1 Months Ended		1 Months Ended		0 Months Ended
	Feb. 29, 2012	Apr. 30, 2012	Feb. 29, 2012	Apr. 30, 2012	Mar. 01, 2012
	Tea Estate	Tea Estate	Tea Estate	Tea Estate	Office Space
	USD ($)	USD ($)	South Africa, Rand	South Africa, Rand	Director of Dunn Roman Holding, Ltd
	acre		USD ($)	ZAR	USD ($)
Lease period	'49 years	'	'	'	'10 years
Land area	8,000	'	'	'	'
Lease terms	'	'	'	'	'
	Under the terms of the lease, the Company is required to pay annual rent of R250,000 ($30,000) plus an annual dividend of 26% of net income generated from the use of the property with a R500,000 ($60,000) annual minimum dividend.
Lease rent due in April 2012	'	$2,610	'	20,883	'
Monthly rent	$30,000	'	$250,000	'	$2,500

Related_Party_Transaction_Narr

Related Party Transaction (Narrative) (Details) (USD $)	Mar. 31, 2014	Jun. 30, 2013	Mar. 01, 2013	Jan. 31, 2014	Dec. 31, 2013
			Three Employment Agreements	Three Employment Agreements	Three Employment Agreements
			Two Officers And Manager	Two Officers And Manager	Two Officers And Manager
Employment agreements description	'	'	'	'	'
			Pursuant to three employment agreements executed on March 1, 2013 by the Company with two of its officers and one manager, the Company is also obligated to issue 4,000,000 common shares at the end of each completed year for services rendered to the Company. The Company valued the 4,000,000 shares at the closing stock price on the date of the executed agreement which was $0.06/share
Stock Subscritption Payable	'	$261,600	'	'	$1,056,600
Shares issued for service, shares	'	'	'	8,000,000	'